Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychosomatics 48:205-210, June 2007
doi: 10.1176/appi.psy.48.3.205
© 2007 Academy of Psychosomatic Medicine
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Lee, K. C.
* Articles by Finley, P. R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Lee, K. C.
* Articles by Finley, P. R.
Related Collections
* Depression
* Syndromes Secondary to General Medical Disorders

Tamoxifen Treatment and New-Onset Depression in Breast Cancer Patients

Kelly C. Lee, Pharm.D., BCPP, G. Thomas Ray, M.B.A., Enid M. Hunkeler, M.A., and Patrick R. Finley, Pharm.D., BCPP

Received March 22, 2006; revised July 28, 2006; accepted August 8, 2006. From Loma Linda Univ.; Kaiser Permanente Division of Research; Univ. of California at San Francisco. Send correspondence and reprint requests to Kelly C. Lee, Pharm.D., BCPP, Assistant Professor, Pharmacy Practice, Loma Linda Univ. School of Pharmacy, 11262 Campus St., West Hall 1333, Loma Linda, CA 92350. e-mail: kclee{at}llu.edu
© 2007 The Academy of Psychosomatic Medicine

The authors conducted a retrospective cohort study of female patients diagnosed with breast cancer (BRCA), evaluating the risk of new-onset depression associated with tamoxifen treatment among those with estrogen receptor-positive (ER+) tumors, versus estrogen receptor-negative (ER–) tumors, who were not receiving tamoxifen. A total cohort of 2,943 patients was identified. The hazard-ratio for new-onset depression in the tamoxifen group was nonsignificant. A post-hoc analysis revealed that chemotherapy and ER+ status were significantly and independently associated with an increased risk for developing depression.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
J. T. PALMER and J. L. PAYNE
Stabilization of Hypomania Following Initiation of Tamoxifen
Am J Psychiatry, May 1, 2008; 165(5): 650 - 651.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2007 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org